Braidwell »

Lexeo Therapeutics shares owned by Braidwell

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Braidwell

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 1.3M 15.68

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note11/0 (Principal)
Apogee Therapeutics (APGE)
Nuvasive Note 0.375% 3/1 (Principal)
Neurocrine Biosciences (NBIX)
Argenx Se Sponsored Adr (ARGX)
Vaxcyte (PCVX)
Neogenomics Note 0.250% 1/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Insmed Note 1.750% 1/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Penumbra (PEN)

View all positions for Braidwell

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics